CRL vs MNKD · rev $2.00B vs rev $199.5M
Charles River Laboratories (CRL) versus MannKind Corp (MNKD) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
MannKind Corp (MNKD) is a biotechnology company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported MNKD revenue for 2026-06-30 was $199.5M. Net income was -$35.7M. MNKD currently screens at market cap $1.28B.
CRL currently screens at market cap $7.78B. MNKD currently screens at market cap $1.28B.
Not investment advice. Open the CRL and MNKD stock pages for the full models.
Not investment advice.